S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:RVNC

Revance Therapeutics SEC Filings & 10K Form

$26.29
+0.58 (+2.26 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$23.92
Now: $26.29
$26.36
50-Day Range
$25.35
MA: $27.75
$29.97
52-Week Range
$11.78
Now: $26.29
$34.62
Volume514,134 shs
Average Volume453,380 shs
Market Capitalization$1.88 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.42

SEC Filings

Revance Therapeutics (NASDAQ:RVNC) SEC Filings

DateFilerForm TypeView
03/05/2021
7:10 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:17 PM
Kolaja Carey OConnor (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:12 PM
Kolaja Carey OConnor (Reporting)
Revance Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2021
3:55 PM
Revance Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2021
3:06 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2021
7:15 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
7:13 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
7:10 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
12:29 PM
ArrowMark Colorado Holdings LLC (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
02/12/2021
3:32 PM
GIC Private Ltd (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
02/10/2021
5:01 AM
Essex Woodlands Health Ventures VIII, L.L.C. (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
02/08/2021
3:40 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
8:16 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
8:16 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
8:16 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
8:15 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
8:12 PM
Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
8:10 PM
Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
10:42 AM
Revance Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/03/2021
7:13 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
1:44 PM
FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
01/29/2021
8:25 AM
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
01/07/2021
7:14 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
7:02 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
7:01 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
6:59 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
7:39 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
7:37 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
4:27 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2020
7:55 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2020
1:43 PM
Revance Therapeutics (Filer)
Form S-3ASR
11/27/2020
12:50 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2020
3:20 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
3:46 PM
Revance Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2020
7:24 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2020
5:57 PM
Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
7:13 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2020
7:34 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:33 PM
Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:32 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:31 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
7:30 PM
Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2020
8:21 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2020
8:19 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 4/A
07/27/2020
6:57 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2020
6:55 PM
Rankin Aubrey (Reporting)
Revance Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2020
7:20 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:18 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
11:15 PM
Revance Therapeutics (Filer)
Form EFFECT
06/24/2020
4:18 PM
Revance Therapeutics (Filer)
Form 424B3
06/23/2020
5:09 AM
Revance Therapeutics (Filer)
Form S-4/A
06/09/2020
8:48 PM
Revance Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
05/21/2020
5:10 AM
Revance Therapeutics (Subject)
Form 425
05/21/2020
5:07 AM
Revance Therapeutics (Filer)
Form 8-K/A
05/19/2020
8:48 PM
Revance Therapeutics (Subject)
Form 425
05/19/2020
7:22 AM
Revance Therapeutics (Subject)
Form 425
05/19/2020
7:18 AM
Revance Therapeutics (Subject)
Form 425
05/19/2020
7:15 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2020
5:45 PM
Beraud Jill (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
5:42 PM
Revance Therapeutics (Issuer)
Vickers Philip J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
5:41 PM
Nolet Chris (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
5:39 PM
GARDNER PHYLLIS (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
5:35 PM
BYRNES ROBERT F (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
5:34 PM
Revance Therapeutics (Issuer)
Russell Angus C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
5:33 PM
Gangolli Julian S (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
3:11 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
4:23 PM
Revance Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2020
6:51 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
7:34 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
3:22 PM
GIC Private Ltd (Filed by)
Revance Therapeutics (Subject)
Form SC 13G
02/19/2020
7:25 PM
Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4/A
02/19/2020
7:23 PM
McDowell Caryn Gordon (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:22 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:21 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:20 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:18 PM
Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:17 PM
Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2020
4:04 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2020
8:10 AM
BlackRock Inc. (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
02/05/2020
2:17 PM
FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
02/03/2020
1:20 PM
Revance Therapeutics (Filer)
Form CT ORDER
01/24/2020
7:22 PM
Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
7:21 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
7:18 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
7:16 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
3:38 PM
Revance Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/17/2020
7:12 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
9:33 AM
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
Form SC 13G/A
01/10/2020
7:11 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
7:05 AM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
2:11 PM
Revance Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/03/2020
5:48 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:46 PM
McDowell Caryn Gordon (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:42 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:00 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
6:57 PM
Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
6:56 PM
Joshi Abhay (Reporting)
Revance Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
7:38 PM
Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/04/2019
4:09 PM
Revance Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
4:08 PM
Revance Therapeutics (Filer)
Form 424B5
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.